Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

209

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

209 results for “valve implantation”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov20/100

Implantation of the Venus P-Valve™ in the Pulmonic Position in Patients With Native Outflow Tracts

ClinicalTrials.gov study NCT02846753. IPD Sharing: NO. Countries: 0. Publications: 0.

closedIPD-NOFeb 2026View details →
zenodo16/100

Dataset related to article "Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications"

<p>This record contains raw data related to article &ldquo;Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications&quot;</p> <p>Abstract</p> <p><strong>Objectives: </strong> To report the experience of a high-volume center with balloon-expandable (BE) stents implantation to manage vascular complications after transcatheter aortic valve replacement (TAVR).</p> <p><strong>Background: </strong> Despite increased operator experience and better devices, vascular complications after TAVR are still a major issue and covered stent implantation is often required.</p> <p><strong>Methods: </strong> We retrospectively collected baseline and procedural data about 78 consecutive patients who underwent BE stent implantation to manage a vascular complication after transfemoral TAVR. Primary endpoints were technical success, incidence of new-onset claudication and need for vascular interventions during long-term follow-up. Secondary endpoints included length of hospitalization, in-hospital and 30-day mortality, and major postoperative complications.</p> <p><strong>Results: </strong> BE stents implantation to manage vascular complications after TAVR was successfully performed in 96.2% of the cases, with bailout surgery required in two cases. One patient suffered in-hospital death. Predischarge Doppler Ultrasound revealed no cases of in-stent occlusion or fracture. At a median follow-up of 429 days (interquartile range, 89-994 days), no cases of symptomatic leg ischemia were reported and only one patient experienced new-onset claudication.</p> <p><strong>Conclusions: </strong> Our experience showed good periprocedural and long-term results of BE covered stent implantation to manage vascular complication after TAVR. Their great radial outward force may guarantee effective hemostasis without necessarily being associated with stent deformation/fracture resulting in restenosis or further interventions. More research is needed to define the role of BE covered stents in this setting.</p>

restrictedNov 2022View details →
zenodo12/100

Computer-based prediction of coronary artery compression in the planning of transcatheter pulmonary valve implantation.

<p>Datset from&nbsp;Pluchinotta FR, Caimi A, Pilati M, Carminati M, Sturla F. Computer-based prediction of coronary artery compression in the planning of transcatheter pulmonary valve implantation. EuroIntervention. 2021 Sep 20;17(7):584-585. doi: 10.4244/EIJ-D-20-01114. PMID: 33433388.</p> <p>&nbsp;</p>

restrictedJan 2022View details →
zenodo12/100

Dataset related to the article "Computed tomography predictors of structural valve degeneration in patients undergoing transcatheter aortic valve implantation with balloon-expandable prostheses"

<p>This record contains raw data related to the article &quot;Computed tomography predictors of structural valve degeneration in patients undergoing transcatheter aortic valve implantation with balloon-expandable prostheses&quot;</p> <p><strong>Objectives: </strong>Computed tomography (CT) provides excellent anatomy assessment of the aortic annulus (AoA) and is utilized for pre-procedural planning of transcatheter aortic valve implantation (TAVI). We sought to investigate if geometrical characteristics of the AoA determined by CT may represent predictors of structural valve degeneration (SVD) in patients undergoing TAVI with balloon-expandable valves.</p> <p><strong>Methods: </strong>Retrospective study on 124 consecutive patients (mean age:79&plusmn;7 years; female: 61%) undergoing balloon-expandable TAVI prospectively enrolled in a registry<strong>. </strong>AoA maximum diameter (D<sub>max</sub>), minimum diameter (D<sub>min</sub>), and area were assessed using pre-procedural CT.&nbsp; SVD was identified during follow-up with transthoracic echocardiography documenting structural prosthetic valve abnormalities with or without hemodynamic changes. &nbsp;</p> <p><strong>Results: </strong>The mean follow up was 5.9&plusmn;1.7 years. SVD was found in 48 out of 124 patients (38%). AoA D<sub>max</sub>, D<sub>min</sub> and area were significantly smaller in patients with SVD compared to patients without SVD (25.6&plusmn;2.2 mm &nbsp;vs. 27.1&plusmn;2.8 mm , p=0.012; 20.5&plusmn;2.1 mm vs. 21.8&plusmn;2.1 mm ,p=0.001 and 419&plusmn;77 mm<sup>2 &nbsp;</sup>vs. 467&plusmn;88 mm<sup>2</sup>,p=0.002, respectively). At univariable analysis, female sex, BSA, 23-mm prosthetic valve size, D<sub>max</sub> &lt;27.1 mm and a D<sub>min</sub> &lt; 19.9 mm were associated with SVD whereas at multivariable analysis, only D<sub>min</sub> &lt;19.9 mm (OR=2.873, 95% CI: 1.191-6.929,p=0.019) and female sex (OR=2.659, 95% CI: 1.095-6.458, p=0.031) were independent predictors of SVD.</p> <p><strong>Conclusions: </strong>Female sex and AoA D<sub>min</sub> &lt; 19.9 mm are associated with SVD in patients undergoing TAVI with balloon expandable valves. When implanting large prostheses in order to avoid paraprosthetic regurgitation, caution should be observed due to the risk of excessive stretching of the AoA D<sub>min,</sub> which may play a role in SVD.</p>

restrictedApr 2022View details →
zenodo12/100

DataSet_Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm

Open the record for dataset details and reuse information.

restrictedcc-by-4.0Oct 2024View details →
zenodo12/100

Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut-R, Portico, and Acurate-NEO

<p>Dataset from&nbsp;Gorla R, De Marco F, Garatti A, Bianchi G, Popolo Rubbio A, Acerbi E, Casenghi M, Spagnolo P, Brambilla N, Testa L, Agnifili ML, Tusa M, Bedogni F. Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut-R, Portico, and Acurate-NEO. Catheter Cardiovasc Interv. 2021 Jan 1;97(1):E135-E145. doi: 10.1002/ccd.28957. Epub 2020 May 13. PMID: 32400068.</p> <p><strong>Abstract</strong></p> <p><strong>Objectives:&nbsp;</strong>To investigate paravalvular leak (PVL) and devices success rates according to aortic angle (AA) in patients undergoing transcatheter aortic valve implantation (TAVI) with three new-generation self-expanding devices.</p> <p><strong>Background:&nbsp;</strong>The impact of aortic angle (AA) on TAVI device success and PVL rates is controversial.</p> <p><strong>Methods:&nbsp;</strong>This retrospective study included 392 patients submitted to TAVI for severe aortic stenosis with Portico, Evolut-R and Acurate-NEO, and available AA measurements at computed tomography (CT) angiography. AA was calculated from the implantation projection and was defined as the angle between the plane of aortic annulus and an ideal horizontal plane. Aorta was defined horizontal if AA&gt;57&deg; (75th percentile).</p> <p><strong>Results:&nbsp;</strong>In the horizontal group, the rates of moderate/severe PVL was higher in the Evolut-R group (20.8%), which was also characterized by a lower implant compared to that of Acurate-NEO, whereas device success was comparable among the three devices. AA was a significant predictor of moderate/severe PVLs (AUC 0.72, p = .002) only in the Evolut-R population. On multivariate analysis, calcium volume 850HU, bicuspid aortic valve, and implantation depth at the level of left coronary cusp were independent predictors of moderate/severe PVL. On univariate analysis in the horizontal aorta population, implantation depth was confirmed among the most significant predictors of moderate/severe PVL.</p> <p><strong>Conclusions:&nbsp;</strong>Despite comparable device success rates, horizontal aorta represented a technical challenge only in the Evolut-R subgroup, which showed higher rates of moderate/severe PVL than Portico and Acurate-NEO, and was associated with a low implant.</p>

restrictedJul 2021View details →
zenodo12/100

One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system

<p>Dataset from&nbsp;Casenghi M, Gorla R, Popolo Rubbio A, De Marco F, Brambilla N, Agnifili M, Testa L, Bedogni F. One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system. Catheter Cardiovasc Interv. 2021 Jul 1;98(1):E145-E152. doi: 10.1002/ccd.29353. Epub 2020 Nov 6. PMID: 33155757.</p> <p>Abstract</p> <p><strong>Objective:&nbsp;</strong>This study sought to investigate the procedural and mid-term outcomes of transcatheter aortic valve implantation for failed surgical bioprostheses (TAVI-ViV) with Portico device.</p> <p><strong>Background:&nbsp;</strong>Limited evidence coming from early experience on Portico system does not allow to fully assess safety and efficacy of this device in this ViV patients.</p> <p><strong>Methods:&nbsp;</strong>From January 2016 up to June 2019, 56 consecutive patients undergoing TAVI-ViV with Portico were prospectively included in our institutional TAVI database.</p> <p><strong>Results:&nbsp;</strong>The prevalent mechanism of failure was stenosis (58.9%); true internal diameter (ID) was &lt;21 mm in 71.4% of cases. Device success rate were 69.6% with 14 (25%) patients showing a residual gradient &ge;20 mmHg, 2 (3.6%) a PVL &ge; moderate and 1 (1.8%) required a second THV implantation due to device embolization. At 1-year follow-up 5 patients (8.9%) died whereas moderate SVD was reported in 2 (3.6%). Patients with a post-procedural mean gradient &ge;20 mmHg showed a significantly higher rate of CV hospitalization (21.4% vs. 2.4%, p = .02) whereas no differences in procedural and 1-year outcomes were noticed according to true ID diameter or degeneration mode. Chimney stenting (ChT) was performed in 23 (41%) patients without significant differences in procedural and 1-year outcomes compared to non-ChT group.</p> <p><strong>Conclusions:&nbsp;</strong>TAVI-ViV with Portico valve was associated with good procedural and 1-year outcomes, even in patients with features of high procedural and anatomical complexity.</p>

restrictedJul 2021View details →
ClinicalTrials.gov12/100

Devitalized Non-valved Pulmonary Artery Allograft Implant for the Repair of Congenital Cardiac Abnormalities

ClinicalTrials.gov study NCT00411658. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
zenodo8/100

Data set from Gorla R, De Marco F, Morganti S, Finotello A, Brambilla N, Testa L, Agnifili ML, Tusa M, Auricchio F, Bedogni F. Transcatheter aortic valve implantation with the Portico and Evolut R bioprostheses in patients with elliptic aortic annulus. EuroIntervention. 2020 Apr 3;15(18):e1588-e1591. doi: 10.4244/EIJ-D-19-00115. PMID: 31186219.

<p>Data set from Gorla R, De Marco F, Morganti S, Finotello A, Brambilla N, Testa L, Agnifili ML, Tusa M, Auricchio F, Bedogni F. Transcatheter aortic valve implantation with the Portico and Evolut R bioprostheses in patients with elliptic aortic annulus. EuroIntervention. 2020 Apr 3;15(18):e1588-e1591. doi: 10.4244/EIJ-D-19-00115. PMID: 31186219.</p> <p>&nbsp; </p><p>&nbsp;</p> <p></p>

restrictedSep 2020View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record